Skip to main content
Top
Published in: Neurological Sciences 9/2020

Open Access 01-09-2020 | Evoked Potential | Original Article

Abnormality of multimodal evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Authors: Edyta Dziadkowiak, Maria Ejma, Malgorzata Wieczorek, Pawel Pec, Krzysztof Slotwiński, Slawomir Budrewicz, Anna Zimny, Magdalena Koszewicz

Published in: Neurological Sciences | Issue 9/2020

Login to get access

Abstract

Introduction

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune disease of the peripheral nervous system, sometimes including the central nervous system. The aim of the study was the assessment of the prevalence of central sensory impairment and its reliance on peripheral nerve damage in patients with CIDP.

Material and methods

Multimodal (visual—VEP, brainstem auditory—BAEP, somatosensory—SEP) evoked potentials (EPs) were studied in 24 patients diagnosed with CIDP. The results were compared with neurographic parameters of sensory responses. The control group consisted of 35 healthy volunteers selected with respect to age and sex.

Results

Mean latency of most components of EP were considerably prolonged in patients compared with the control group. There were no correlations between the P100 VEP latency and the peripheral sensory parameters. Statistically significant negative correlations were obtained between BAEP and SEP responses and the amplitude and sensory conduction velocity of peripheral nerves. The inter-latencies were also longer.

Conclusions

The authors indicated to the possibility of central sensory involvement in patients with CIDP, especially based on the prolonged inter-latency of BAEPs with simultaneously confirmed root affection. The severity of central damage correlates with the degree of peripheral nerve impairment.
Literature
1.
go back to reference Austin JH (1958) Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 81:157–192CrossRef Austin JH (1958) Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 81:157–192CrossRef
2.
go back to reference Dyck PJ, O’Brien PC, Oviatt KF, Dinapoli RP, Daube RP, Bartleson JD, Mokri B, Swift T, Low PA, Windebank AJ (1982) Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11:136–141CrossRef Dyck PJ, O’Brien PC, Oviatt KF, Dinapoli RP, Daube RP, Bartleson JD, Mokri B, Swift T, Low PA, Windebank AJ (1982) Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11:136–141CrossRef
3.
go back to reference Sanvito L, Makowska A, Mahdi-Rogers M, Hadden RDM, Peakman M, Gregson N, Nemni R, Hughes RAC (2009) Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 80:333–338CrossRef Sanvito L, Makowska A, Mahdi-Rogers M, Hadden RDM, Peakman M, Gregson N, Nemni R, Hughes RAC (2009) Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 80:333–338CrossRef
4.
go back to reference Fan C, Jin H, Hao H, Gao F, Sun Y, Lu Y, Liu Y, Lv P, Cui W, Teng Y, Huang Y (2017) Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients. Muscle Nerve 55:470–475CrossRef Fan C, Jin H, Hao H, Gao F, Sun Y, Lu Y, Liu Y, Lv P, Cui W, Teng Y, Huang Y (2017) Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients. Muscle Nerve 55:470–475CrossRef
5.
go back to reference PeiLim J, Devaux J, Yuki N (2014) Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Autoimmun Rev 13:1070–1078CrossRef PeiLim J, Devaux J, Yuki N (2014) Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Autoimmun Rev 13:1070–1078CrossRef
6.
go back to reference Melody R, Stephen JR (2018) Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health. Am J Manag Care 24(17suppl):S371–S379 Melody R, Stephen JR (2018) Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health. Am J Manag Care 24(17suppl):S371–S379
8.
go back to reference Mendel JR, Kolkin S, Kissel JT, Weiss KL, Chakeres DW, Rammohan Kottil W (1987) Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculopathy. Neurol 37:1291–1294CrossRef Mendel JR, Kolkin S, Kissel JT, Weiss KL, Chakeres DW, Rammohan Kottil W (1987) Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculopathy. Neurol 37:1291–1294CrossRef
9.
go back to reference Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN (2010) Peripheral Nerve Society: European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17:356–363CrossRef Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN (2010) Peripheral Nerve Society: European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17:356–363CrossRef
10.
go back to reference Cruccu G, Aminoff MJ, Curio G, Guerit JM, Kakini R, Mauguiere F, Rossini PM, Treede RD, Garcia-Larrea L (2008) Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 119:1705–1719CrossRef Cruccu G, Aminoff MJ, Curio G, Guerit JM, Kakini R, Mauguiere F, Rossini PM, Treede RD, Garcia-Larrea L (2008) Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 119:1705–1719CrossRef
11.
go back to reference Holder GE, Celesia GG, Miyake Y, Tobimatsu S, Weleber RG (2010) International Federation of Clinical Neurophysiology:.International Federation of Clinical Neurophysiology: recommendations for visual system testing. Clin Neurophysiol 121:1393–1409CrossRef Holder GE, Celesia GG, Miyake Y, Tobimatsu S, Weleber RG (2010) International Federation of Clinical Neurophysiology:.International Federation of Clinical Neurophysiology: recommendations for visual system testing. Clin Neurophysiol 121:1393–1409CrossRef
12.
go back to reference Lee E-M, Seok HY, Park KD, Seo D-W (2018) Evoked potentials: basic requirements and guidelines for writing reports. Ann Clin Neurophysiol 20:18–25CrossRef Lee E-M, Seok HY, Park KD, Seo D-W (2018) Evoked potentials: basic requirements and guidelines for writing reports. Ann Clin Neurophysiol 20:18–25CrossRef
13.
go back to reference Oh SJ (2003) Clinical electromyography: nerve conduction studies. Lippincott, Williams and Wilkins, Philadelphia, pp 1705–1719 Oh SJ (2003) Clinical electromyography: nerve conduction studies. Lippincott, Williams and Wilkins, Philadelphia, pp 1705–1719
14.
go back to reference Willison HJ, Paterson G, Veitch J, Inglis G, Barnett SC (1993) Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 56:1178–1183CrossRef Willison HJ, Paterson G, Veitch J, Inglis G, Barnett SC (1993) Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 56:1178–1183CrossRef
15.
go back to reference Del Sordo E, Casali S, Ginanneschil F, Insana L, Capoccitti G, Cardinali C, Battista D, Borgheresi A, Cincotta M, Borsini W, Giannini F (2015) CANOMAD: clinical and neurophysiological findings in two cases. Clin Neurophysiol 126:e21–e22CrossRef Del Sordo E, Casali S, Ginanneschil F, Insana L, Capoccitti G, Cardinali C, Battista D, Borgheresi A, Cincotta M, Borsini W, Giannini F (2015) CANOMAD: clinical and neurophysiological findings in two cases. Clin Neurophysiol 126:e21–e22CrossRef
16.
go back to reference Sanvito L, Rajabally YA (2011) Optic neuropathy associated with CANOMAD: description of 2 cases. Muscle Nerve 44:451–455CrossRef Sanvito L, Rajabally YA (2011) Optic neuropathy associated with CANOMAD: description of 2 cases. Muscle Nerve 44:451–455CrossRef
17.
go back to reference Knopp M, Leese RJ, Martin Lamb D, Rajabally YA (2014) Optic and auditory pathway dysfunction in demyelinating neuropathies. Acta Neurol Scand 130:53–57CrossRef Knopp M, Leese RJ, Martin Lamb D, Rajabally YA (2014) Optic and auditory pathway dysfunction in demyelinating neuropathies. Acta Neurol Scand 130:53–57CrossRef
18.
go back to reference Cabrera-Lima AV, Gutiérrez J, Martínez E, Estrada R (1999) Electrophysiological characteristics of inflammatory demyelinating chronic polyneuropathy. Rev Neurol 28:353–357PubMed Cabrera-Lima AV, Gutiérrez J, Martínez E, Estrada R (1999) Electrophysiological characteristics of inflammatory demyelinating chronic polyneuropathy. Rev Neurol 28:353–357PubMed
19.
go back to reference Ormerod IE, Waddy HM, Kermode AG, Murray NM, Thomas PK (1990) Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 53:789–793CrossRef Ormerod IE, Waddy HM, Kermode AG, Murray NM, Thomas PK (1990) Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 53:789–793CrossRef
20.
go back to reference Graf J, Jansen L, Ingwersen J, Ringelstein M, Harmel J, Rybak J, Kolbe R, Rhöse L, Gemerzki L, Lee JI, Klistorner A, Guthoff R, Hartung HP, Aktas O, Albrecht P (2018) Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathy. Ann Clin Transl Neurol 5:952–961CrossRef Graf J, Jansen L, Ingwersen J, Ringelstein M, Harmel J, Rybak J, Kolbe R, Rhöse L, Gemerzki L, Lee JI, Klistorner A, Guthoff R, Hartung HP, Aktas O, Albrecht P (2018) Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathy. Ann Clin Transl Neurol 5:952–961CrossRef
21.
go back to reference Stojkovic T, de Seze J, Hurtevent JF, Arndt C, Beaume A, Hache JC, Vermersch P (2000) Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 111:2285–2291CrossRef Stojkovic T, de Seze J, Hurtevent JF, Arndt C, Beaume A, Hache JC, Vermersch P (2000) Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 111:2285–2291CrossRef
22.
go back to reference Sun RD, Fu B, Jiang J (2017) Role of short-latency somatosensory evoked potentials in the diagnosis of chronić inflammatory demyelinating polyneuropathy. Zhongguo Dang Dai Er Ke Za Zhi 19:545–548PubMed Sun RD, Fu B, Jiang J (2017) Role of short-latency somatosensory evoked potentials in the diagnosis of chronić inflammatory demyelinating polyneuropathy. Zhongguo Dang Dai Er Ke Za Zhi 19:545–548PubMed
23.
go back to reference Salhi H, Corcia P, Remer S, Praline J (2014) Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Neurophysiol 31:241–245CrossRef Salhi H, Corcia P, Remer S, Praline J (2014) Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Neurophysiol 31:241–245CrossRef
24.
go back to reference Koutlidis RM, Ayrignac X, Pradat P-F, Le Forestier N, Leger J-M, Salachas F, Maisonobe T, Fournier E, Viala K (2014) Segmental somatosensory-evoked potentials as a diagnostic tool in chronic inflammatory demyelinating polyneuropathies, and other sensory neuropathies. Neurophysiol Clin 44:267–280CrossRef Koutlidis RM, Ayrignac X, Pradat P-F, Le Forestier N, Leger J-M, Salachas F, Maisonobe T, Fournier E, Viala K (2014) Segmental somatosensory-evoked potentials as a diagnostic tool in chronic inflammatory demyelinating polyneuropathies, and other sensory neuropathies. Neurophysiol Clin 44:267–280CrossRef
25.
go back to reference Hanajima R, Terao Y, Yugeta A, Hamada M, Shirota Y, Ohminami S, Nakatani-Enomoto S, Tsuji S, Ugawa Y (2010) Prominent cauda equina involvement in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 290:112–114CrossRef Hanajima R, Terao Y, Yugeta A, Hamada M, Shirota Y, Ohminami S, Nakatani-Enomoto S, Tsuji S, Ugawa Y (2010) Prominent cauda equina involvement in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 290:112–114CrossRef
26.
go back to reference Duggins AJ, McLeod JG, Pollard JD, Davies L, Yang F, Thompson EO, Soper JR (1999) Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 122:1383–1390CrossRef Duggins AJ, McLeod JG, Pollard JD, Davies L, Yang F, Thompson EO, Soper JR (1999) Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 122:1383–1390CrossRef
27.
go back to reference Schady W, Goulding PJ, Lecky BR, King RH, Smith CM (1996) Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 61:636–640CrossRef Schady W, Goulding PJ, Lecky BR, King RH, Smith CM (1996) Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 61:636–640CrossRef
Metadata
Title
Abnormality of multimodal evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Authors
Edyta Dziadkowiak
Maria Ejma
Malgorzata Wieczorek
Pawel Pec
Krzysztof Slotwiński
Slawomir Budrewicz
Anna Zimny
Magdalena Koszewicz
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 9/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04351-3

Other articles of this Issue 9/2020

Neurological Sciences 9/2020 Go to the issue